Stay updated with breaking news from Mark Vaeck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Issuer: CureVac / Key word(s): Alliance25.05.2022 / 13:00 The issuer is solely responsible for the content of this announcement.CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development CureVac is broadening its foundation in oncology, leveraging recent progress with it...
Issuer: CureVac / Key word(s): Alliance CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine ...
CureVac is broadening its foundation in oncology, leveraging recent progress with its second-generation mRNA backboneThe partnership combines CureVac's mRNA technology with myNEO's platform for the discovery
DGAP-News: CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development
InteRNA Technologies, a clinical-stage biotech company developing microRNA (miRNA)-based therapeutics with a focus on cancer, announced today the appointment of Andrea van Elsas, PhD, as a new member